Refine by
57 results found
-
Regulatory Comment to SAMHSA on Research and Innovation and Mental Health Funding
NAMI’s comments on SAMHSA’s 2023–2026 Draft Strategic Plan, offering strong support for the agency’s five priority areas and recommendations on ways to further strengthen the Strategic Plan. -
Letter to Congressional Committee Leadership on Research and Innovation & Criminal Justice
Letter to House and Senate Appropriations Committee leadership requesting $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health and $1 million for the National Institute of Justice to conduct public health research into firearm morbidity and mortality prevention. -
Letter to FDA Commissioner & HHS Secretary on Research and Treatment Innovation
Letter to HHS Secretary Becerra and FDA Commissioner Califf urging the Federal Drug Administration FDA to reissue its ban of electrical stimulation devices used to treat self-injurious or aggressive behavior. -
Regulatory Comment to the Office of Science and Technology Policy on Criminal Justice and Research and Treatment Innovation
Regulatory comment to White House Office of Science & Technology Policy in response to the RFI on “Advancing Effective, Accountable Policing and Criminal Justice Practices to Enhance Public Trust and Public Safety.” -
Regulatory Comment to SAMHSA on Research and Innovation Treatment & Crisis Services
Regulatory comments to SAMHSA Assistant Secretary Delphin-Rittmon, in response to the Revised Draft of the Updated Certification Criteria for the Certified Community Behavioral Health Clinics (CCBHC). -
Letter to President Biden on Research and Innovation
Letter to President Biden, urging the Administration to convene a summit of stakeholders from across the health care system to identify immediate and long-term solutions on the issue of emergency room boarding. -
Letter to Congressional Committee Leadership on Research and Innovation and Mental Health Funding
Letter to Senate HELP committee leadership, expressing support for including funding to enhance the evidence-based Collaborative Care Model (CoCM) within H.R. 7666, the Restoring Hope for Mental Health and Well-Being Act of 2022. -
Letter to Congressional Bill Sponsors on Research and Innovation & Child and Adolescent Mental Healthh
Letter to Senators Smith and Murkowski, expressing support for the Improving Data Collection for Adverse Childhood Experiences Act, which will build upon previous studies on Adverse Childhood Experiences (ACEs) in innovative and equitable ways. -
Letter to Congressional Committee Leadership on Research and Innovation
Letter to House & Senate Appropriations Committee leadership, urging House and Senate Appropriations leadership to provide a robust funding allocation for the FY23 Labor-HHS-Education (“Labor-H”) appropriations bill. -
Letter to Congressional Committee Leadership on Research & Innovation
Letter to Senate HELP and House Energy & Commerce Committees leadership, expressing support for the Anna Westin Legacy Act of 2022 (S.3686/H.R.7249), which will reauthorize and expand the Substance Abuse and Mental Health Services Administration’s Center of Excellence for Eating Disorders.